Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study

被引：0

作者：

Ashish Sharma

Francesco Bandello

Anat Loewenstein

Baruch D. Kuppermann

Paolo Lanzetta

Dinah Zur

Assaf Hilely

Matias Iglicki

Daniele Veritti

Angeline Wang

Fernando Miassi

David Bellocq

Leandro Cabral Zacharias

Deepika Makam

Nilesh Kumar

Nikulaa Parachuri

Alan K. Barriera

Rohini Sharma

Hafeez Faridi

Thibaud Mathis

Laurent Kodjikian

机构：

[1] Lotus Eye Hospital and Institute,Scientific Institute San Raffaele

[2] University Vita-Salute,Division of Ophthalmology, Tel Aviv Sourasky Medical Center Affiliated to the Sackler Faculty of Medicine

[3] Tel Aviv University,Gavin Herbert Eye Institute

[4] University of California,Department of Ophthalmology

[5] University of Udine,Private Retina Service

[6] University of Buenos Aires,Department of Ophthalmology, Croix

[7] Rosario Retina Clinic,Rousse Hospices Civils de Lyon

[8] University of Lyon,UMR

[9] University of Lyon,CNRS 5510 MatéisVilleurbanne

[10] University of São Paulo,University of São Paulo Medical School

[11] HCLOE Eye Hospital,Department of Healthcare

[12] The TIPS Global Institute,College of Pharmacy

[13] Chicago State University,undefined

来源：

International Ophthalmology | 2020年 / 40卷

关键词：

Cystoid macular edema; Intravitreal injection; Irvine Gass syndrome; Management; Pharmacotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3067 / 3075

页数：8

共 26 条

[1] Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study
Sharma, Ashish
Bandello, Francesco
Loewenstein, Anat
Kuppermann, Baruch D.
Lanzetta, Paolo
Zur, Dinah
Hilely, Assaf
Iglicki, Matias
Veritti, Daniele
Wang, Angeline
Miassi, Fernando
Bellocq, David
Zacharias, Leandro Cabral
Makam, Deepika
Kumar, Nilesh
Parachuri, Nikulaa
Barriera, Alan K.
Sharma, Rohini
Faridi, Hafeez
Mathis, Thibaud
Kodjikian, Laurent
INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (11) : 3067 - 3075
[2] Intravitreal ranibizumab for the treatment of irvine-gass syndrome
Chatziralli, I.
Parikakis, E.
Peponis, V.
Tsiotra, V.
Mitropoulos, P.
ACTA OPHTHALMOLOGICA, 2014, 92
[3] Intravitreal pegaptanib sodium for Irvine-Gass syndrome
Querques, G.
Iaculli, C.
Delle Noci, N.
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (01) : 138 - 141
[4] Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome
Mitropoulos, Panagiotis G.
Chatziralli, Irini P.
Peponis, Vasileios G.
Drakos, Evangelos
Parikakis, Efstratios A.
OCULAR IMMUNOLOGY AND INFLAMMATION, 2015, 23 (03) : 225 - 231
[5] Intravitreal triamcinolone acetonide for treatment of patients with Irvine-Gass syndrome
Boscia, F
Dammacco, R
Quaranta, G
Ferrari, TM
Sborgia, C
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U675 - U675
[6] Intravitreal Ranibizumab for the Treatment of Cystoid Macular Edema in Irvine-Gass Syndrome
Demirel, Sibel
Batioglu, Figen
Ozmert, Emin
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 636 - 639
[7] Current Management Options in Irvine-Gass Syndrome: A Systemized Review
Orski, Michal
Gawecki, Maciej
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
[8] Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome
Guclu, Hande
Gurlu, Vuslat Pelitli
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (02) : 258 - 267
[9] Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome
Hande Guclu
Vuslat Pelitli Gurlu
International Journal of Ophthalmology, 2019, (02) : 258 - 267
[10] Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases
Keilani, Chafik
Halalchi, Aziz
Djeugue, Desire Wakpi
Regis, Anne
Abada, Samir
THERAPIE, 2016, 71 (05): : 457 - 465

← 1 2 3 →